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Background: Social-stress mouse model, based on the resident-intruder paradigm was used to simulate features
of human post-traumatic stress disorder (PTSD). The model involved exposure of an intruder (subject) mouse to a
resident aggressor mouse followed by exposure to trauma reminders with rest periods. C57BL/6 mice exposed to
SJL aggressor mice exhibited behaviors suggested as PTSD-in-mouse phenotypes: intermittent freezing, reduced
locomotion, avoidance of the aggressor-associated cue and apparent startled jumping. Brain tissues (amygdala,
hippocampus, medial prefrontal cortex, septal region, corpus striatum and ventral striatum) from subject (aggressor
exposed: Agg-E) and control C57BL/6 mice were collected at one, 10 and 42 days post aggressor exposure sessions.
Transcripts in these brain regions were assayed using Agilent’s mouse genome-wide arrays.
Results: Pathways and biological processes associated with differentially regulated genes were mainly those
thought to be involved in fear-related behavioral responses and neuronal signaling. Expression-based assessments
of activation patterns showed increased activations of pathways related to anxiety disorders (hyperactivity and fear
responses), impaired cognition, mood disorders, circadian rhythm disruption, and impaired territorial and aggressive
behaviors. In amygdala, activations of these pathways were more pronounced at earlier time-points, with some
attenuation after longer rest periods. In hippocampus and medial prefrontal cortex, activation patterns were
observed at later time points. Signaling pathways associated with PTSD-comorbid conditions, such as diabetes,
metabolic disorder, inflammation and cardiac infarction, were also significantly enriched. In contrast, signaling
processes related to neurogenesis and synaptic plasticity were inhibited.
Conclusions: Our data suggests activations of behavioral responses associated with anxiety disorders as well as
inhibition of neuronal signaling pathways important for neurogenesis, cognition and extinction of fear memory.
These pathways along with comorbid-related signaling pathways indicate the pervasive and multisystem effects of
aggressor exposure in mice, potentially mirroring the pathologic conditions of PTSD patients.
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Post-traumatic stress disorder (PTSD) is an anxiety dis-
order, which can result from exposure to a traumatic event
(s). PTSD can manifest itself in a number of ways such as a
persistent re-experiencing of the traumatic event, arousal,
avoidance, numbing, fear, and/or startle responses [1].
PTSD patients may also exhibit impaired cognition, work-
ing memory deficit, mood disorders and diminished social* Correspondence: marti.jett-tilton.civ@mail.mil
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unless otherwise stated.activities [2]. Common PTSD co-morbid conditions include
depression, obesity, diabetes, peripheral inflammation, car-
diovascular problems, and metabolic disorders [3].
Anxiety disorders, including PTSD, encompass hetero-
geneous conditions that are associated with abnormalities
in the fear response circuitry in brain structures such as
the medial prefrontal cortex, amygdala, hippocampus, and
nucleus accumbens (Additional file 1: Figure S1). Changes
in the activity and functional connectivity of these brain
regions lead to abnormalities in the perception and inter-
pretation of traumatic events and to the development and
maintenance of anxiety disorders [4-7]. For example, theThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ing, in trauma memory consolidation, and retrieval (intru-
sive re-experiencing of the traumatic event); the amygdala
(AY) is associated with cue conditioning, hyper-vigilance,
heightened arousal, learning, and expressing fear behavior
[8,9]; the medial prefrontal cortex (MPFC) is involved in
cognition, emotional regulation, and fear extinction; and
the nucleus accumbens (NAc, part of the ventral striatum,
VS) is associated with reward-related behavioral abnor-
malities such as depression [10]. Other brain regions, such
as corpus striatum (ST) and septal region (SE), are impli-
cated in processing and responding to reward and aversive
stimuli, lack of motivation, and recall of intrusive trau-
matic cues in the form of flashbacks [11,12].
Impaired extinction of fear-potentiated startle and en-
hanced cue conditioning in these brain regions (of trau-
matized patients and animal models) can be manifested
in the forms of hypervigilance, arousal, and avoidance
symptoms [13]. In particular, failure to inhibit fear learn-
ing and fear memory consolidation are considered to be
precipitating factors in the development of PTSD [14].
With regards to cognition, PTSD patients showed signifi-
cantly less activation in sensory association areas, suggest-
ing diversion of attention from the presented stimuli,
perhaps due to increased focus on the elicited trauma
memory [15-17]. It has been suggested that cognitive im-
pairments exhibited by people with PTSD result from in-
trusive flashback memories that transiently interfere with
ongoing cognitive processing [17].
Molecular and cellular encoding of traumatic events and
behavioral responses are presumed to be reflected in synap-
tic plasticity or changes in the activity and functional con-
nectivity among AY, HC and mPFC [18-21]. Specifically,
changes in signaling molecules associated with synaptic
transmission and plasticity are implicated as a primary sub-
strate for fear learning and memory, thus putatively leading
to PTSD in human and to behavioral features of PTSD in
animals. This could occur because the expression levels
and types of signaling molecules determine spike-timing-
dependent plasticity in relation to traumatic perceptions
and responses. This could lead to either a long-term synap-
tic potentiation (LTP) increase in synaptic strength and in-
crease in excitatory post-synaptic potential, potentially
enhancing the manifestation of traumatic disorder, or to
long-term synaptic depression (LTD) leading to a decrease
in synaptic strength and a decrease in EPSP size, suppres-
sesing fear extinction processes [22,23]. Understanding the
molecular underpinnings of fear learning and memory fol-
lowing trauma exposure or presentation of an aversive
stimulus would be critical to identifying prognostic bio-
markers and for developing an intervention to apply post-
trauma, before the onset of pathological symptoms.
Subsequent to trauma exposure, the symptoms of
stress reaction typically develop over varying amounts oftime (typically from days to months), resulting in hetero-
geneous pathologies. The heterogeneity of PTSD symp-
toms suggests that its etiology is diverse, and there
are still no known or accepted molecular biomarkers
for diagnosis of PTSD. Current pharmacotherapies for
PTSD are applicable after symptoms manifest, and pri-
marily consist of selective serotonin reuptake inhibitors.
There are no FDA-approved pharmacological interven-
tions available for the treatment of traumatized individ-
uals to forestall the development of PTSD prior to the
onset of pathological symptoms. Many factors hinder
advances towards identifying prognostic biomarkers and
potential pre-symptomatic therapeutic targets for PTSD.
One of these factors, despite great advances in brain
imaging, is a lack of real time visualization of cellular
reactions in specific brains regions of individuals at
risk for PTSD and patients with the disorder. Hence
animal models are required to obtain appropriate brain
regions for genomic, genetic and other high throughput
molecular studies.
Increasing evidence suggests that precipitating factors
such as chronic stress (including social defeat stress) in-
duce changes in the functional connectivity within the
fear circuitry, and such changes mediate trauma-related
behavior alerations in animal models of anxiety disorders
[24,25]. Such behavioral responses include startle re-
sponse, hyperactivity, avoidance, freezing, grooming,
rearing, and deficiencies in novel object recognition and
in territorial behavior. The molecular and cellular origins
of these behavioral abnormalities have been suggested to
include changes in glutamatergic and GABAergic synap-
tic plasticity, dopamine neuron excitability, epigenetic
and transcriptional mechanisms, and neurotrophic factors
[26-28]. However, the genome-wide molecular basis for the
interplay of different behaviors in anxiety disorders is not
very clear. We hypothesize that chronic exposure to stress
alters gene expression patterns which are important for the
functional activity, connectivity and signaling among neu-
rons of these brain regions, thus leading to the develop-
ment of anxiety and depression-like behaviors.
We and others have shown that aggressor exposed
(Agg-E) social-stress mouse models elicit behaviors such
as submissive posture, freezing during locomotion, vertical
rearing, grooming, aggressor barrier avoidance, hyper-
activity, jumping, and impaired cognition (deficiency in
novel object recognition) [29,30]. These might be consid-
ered to be PTSD-like phenotypes.
In this study, our objective was to correlate our previ-
ous behavioral observations [29] with changes at the
molecular level in brain regions critical for fear learning,
fear memory consolidation/extinction and fear response/
expression. Here we attempted to understand how envir-
onmental stimuli (exposure to aggressor) and transcrip-
tome interact and influence each other in the context of
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to our understanding and treatment of stress-related dis-
orders such as PTSD (interaction of genes, brain, and
behavior). Although a candidate gene approach, in con-
junction with endophenotyping, would be important to
solve the puzzle of PTSD etiology, genome-wide screen-
ing for transcriptome changes has the potential to lead
to new candidate targets and pathways specific to stress
disorders, and to facilitate or hasten the one gene or few
candidate genes approaches. It may also reveal new mo-
lecular mechanisms and connections, which may not be
apparent from a single gene or genotyping approach.
Toward this goal, we performed global gene expression
profiling of different brain regions implicated in fear and
anxiety processing. Genome-wide transcriptome changes
were assessed in brain regions collected from male C57BL/
6 mice exposed to male SJL aggressor mice. The behaviors
elicited suggest a possible PTSD-in-mouse phenotype:
immobility, avoidance of aggressor-associated stimuli
(aggressor odor), jumping (indicating hyperactivity), freez-
ing during locomotion (suggesting fear), and reduced loco-
motion. Transcriptome alterations in six brain regions:
HC, AY, MPFC, VS (contains NAc), SE, and ST (Additional
file 1: Figure S1) from Agg-E mice were measured using
Agilent’s mouse genome-wide arrays to identify transcripts
and associated pathways that reveal potential molecular
mechanisms of stress disorders. Profiles of genome-wide
transcriptome changes were carried out at different time
points to assess how the time course dynamics of tran-
scripts indicate molecular events associated with traumatic
fear learning and memory along the developmental trajec-
tories of traumatic-anxiety disorders.
We identified a number of differentially expressed genes
(DEGs) across different brain regions and time points.
Functional and pathway analyses of DEGs suggested pos-
sible roles in anxiety-related behavioral responses, synaptic
plasticity, neurogenesis, inflammation, obesity (metabolic
disorder), and cardiac infarction. In particular, transcripts
important for the synthesis of neurotransmitters, gener-
ation and development of the hippocampus, axonogenesis,
dendritic branching, splice variant processing, and dopa-
minergic and serotonergic pathways were affected.
Results
Behavioral evaluation of mouse model
We established [29] a rodent model manifesting PTSD-
like behavioral features. We believe that, because the stres-
sor depends on antagonistic social interaction within a
conspecific, this model offers potential advantages over
the brief foot-shock model in simulating traumatic events
of conflict-like situations. Especially as both the stressor
and the behaviors assessed are essentially within the social
realm. Concerns [31] that the repeated social stress model
may allow the animals to habituate rather than triggeringthe PTSD-like features was countered by implementing
the ‘randomness’ in the occurrence of the life-threatening
conditions. Thereby we incorporated a critical dimension
of traumatic psychosocial stress with regard to the “etho-
logical validity” of the unpredictable and uncontrollable
nature of the PTSD simulating trauma. The hypothesis
was further validated as we found the mice displaying
many traumatic features after a long time interval. The
‘habituation’ related concern was further mitigated as the
stressed mice displayed significantly reduced urine mark-
ings, a signature of inhibited territorial behavior in the
course of 10-day stress session. Territorial urine markings
of Agg-E mice were three-fold lower than those of control
mice with linear regression significance of p = 0.02 [29].
Post 10-day Agg-E, stressed mice maintained decreased
but not significant urine marking (p = 0.07) compared to
the controls. During the same time course, we observed
an increased bodyweights of Agg-E mice. Linear regres-
sion model showed significant difference (p < 0.001) in
gain of body weights by the stressed cohorts. In addition,
Agg-E groups showed significantly increased temperature
(p = 0.006), and 30% decreased but not statistically signifi-
cant corticosterone levels ((p = 0.06).
In addition, the present model supports a set of prede-
fined validity criteria for an animal model of PTSD
[31,32]. For instance, the “face validity” of symptoms simu-
lating PTSD-like features was manifested by introducing
the stressed mice to the contextual cues immediately after
withdrawing the trauma as well as at a delayed interval or
rest period (the latter being equivalent to nearly three
years of human life). We observed a significant display in
associative fear memory, anxiety and hypo- and hyper-
responses immediately after the trauma-withdrawal; and
many of these behavioral traits, such as the restrained tail
rattling (an agonistic behavior, hypo-response) and groom-
ing (an anxiety-like feature, hyper-response) sustained
through the delayed interval. Specifically, while the num-
ber of control animals displaying tail rattling gradually
increased with the passage of 42 days, none of the stressed
mice displayed tail rattling even 42 days after the end
of stress exposure. Moreover, the duration of grooming
displayed by the stressed mice remained 2.5 fold higher
(p < 0.05) than the controls, after 42 days post-10 days of
Agg-E. Likewise, freezing, a hypo-active fear response
remained significant from day 1 (p < 0.0001) to 28 days
(p < 0.05) post-10 day stress. Suppressing a natural instinct
namely the vigilance of novel object, the stressed animals,
showed significant avoidance of the aggressor’s partition
(p < 0.0001) 1 day after stress; however Agg-E mice exhib-
ited decreased avoidance at 42 days of rest (delayed)
period post 10 day exposure session.
The present model attested an essential criterion of
PTSD namely the persistence (or re-emergence) of a con-
textual fear memory. We further noticed a ‘dose-response’
Muhie et al. Molecular Brain  (2015) 8:14 Page 4 of 21in displaying PTSD feature, as in comparing the 5-day and
10-day long traumatic burdens, the later proved more
deleterious. The “construct validity” of the rodent PTSD
model representing the cellular and molecular processes
was underlined by the atypical increase of many blood
cells’ load, previously associated with stress [33]. Signifi-
cant myocardial atrophies caused by this model persisted
after the delayed interval, which potentially implied the
cardiac damages caused by PTSD primarily on the war
veterans. Additional histological analysis showed lack of
the expected increase in dendritic spine density of pyram-
idal neurons in MPFC (medial prefrontal cortex, an essen-
tial brain region for fear memory extinction and memory
sorting). Together this model strategically modified the so-
cial stress model to reasonably simulate aspects of
combat-related PTSD, and validated some of the essential
criteria of PTSD in rodent-models.
Gene expression analyses of brain regions
Feature-extracted and quantile normalized microarray
data from brain regions were analyzed to assess stress-
affected biological processes and pathways in Agg-E
mice as compared to controls.
Differentially expressed genes (DEGs), compared between
Agg-E and control (C-ctrl) mice for each brain region (AY,
HC, MPFC, SE, ST and VS), were identified at four differ-
ent time points (T5R1, T5R10, T10R1 and T10R42)
(Table 1) using Moderated T-test, p ≤ 0.05 (Figure 1). For
the 10-day Agg-E groups, there were more DEGs after
the longer rest period (T10R42) except for ST which
showed a large decrease in DEGs as compared to the
T10R1 group. The numbers of DEGs of 5-day Agg-E
groups were greater at T5R1 for AY, HC and SE regions;
at T5R10, the numbers of DEGs increased for MPFC,
ST and VS, while by contrast the numbers were greatly
decreased for HC and SE.
The greater divergence between 10-day Agg-E and C-ctrl
groups after 42 days of rest may be due to either of two














*collected brain regions: HC: hippocampus, AY: amygdala, MPFC: medial prefrontal
ST: corpus striatum.the C-ctrl mice from handling, confinement and hunger
stressors compared to the rate of recovery of the Agg-E
groups. Another factor may be that multiple processes lead-
ing to a return to homeostasis versus further consolidation
of PTSD-like disorders (or combination of both) may in-
volve expression of many more and different sets of genes
in the Agg-E mice.
Functional and pathway enrichments and visualization of
associated networks
Functional and pathway enrichments of DEGs of the dif-
ferent brain regions led to the identification of modular-
networks (functional interaction networks) consisting of
genes implicated in anxiety-related behavioral responses
and the underlying synaptic processes (Figure 2). Each
module of this network has many more member DEGs,
which were excluded for clarity (visualization) to show
only representative members. Also, the list of pathway
and functional modules identified were longer than
shown in Figure 2 (Additional file 2: Table S1). Member
DEGs involved in long-term memory, associative learn-
ing, and limbic system development were largely from
the HC; DEGs associated with startle and fear responses
were largely from the AY; and DEGs associated with cir-
cadian rhythm, cognition, neurogenesis, locomotory be-
havior, dopaminergic and serotonergic pathways were
from different brain regions.
Separation of each module, adding more member
DEGs, and coloring nodes based on their expression
level in HC and AY for the one-day post 10-day Agg-E
group (T10R1), showed how a particular behavioral re-
sponse or biological process behaves in these two im-
portant brain regions (Figures 3 and 4). For example,
modular network DEGs involved in associative learning
were largely induced in AY, whereas DEGs associated
with aggressive and territorial behaviors were largely
suppressed in AY, suggesting involvement in impaired
territorial and aggressive behavior (Figure 3). This infer-
ence is also corroborated by the finding of significantssues












cortex, VS: ventral striatum or nucleus accumbens, SE: septal region,
Figure 1 Differentially expressed genes (DEGs) across brain regions at different time points (T5R1, T5R10, T10R1 and T10R42). The
scatter plots show both log2 -fold changes and negative log10 p-values in six brain regions (across) and four time-points (down); the numbers of
up- and down-regulated transcripts in each group are also shown. Key: amygdala (AY), hippocampus (HC), medial prefrontal cortex (MPFC), septal
region (SE), corpus striatum (ST), and ventral striatum (VS), T: number of days of trauma or aggressor exposure; R: post-trauma tissue
collection days; Agg-E: aggressor-exposed.
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ated with circadian rhythm were suppressed in AY, sug-
gesting a circadian rhythm disruption, whereas those
involved in corticotrophin releasing hormone signaling
were largely induced in AY (Figure 4), indicating aggres-
sion (trauma) potentiated hypothalamic-pituitary-adrenal
(HPA)-axis signaling, thus leading to anxiety-related be-
havioral responses. The expression patterns of some of
the important nodes showed different directions in AY
and HC. The differential responses between these two
important brain regions are consistent with suboptimal
communication between the putative fear response center
(AY) and the center associated with contextual processing
(HC). Examining fewer member genes among thoseassociated with some of stress-induced processes and
pathways such as glucocorticoid receptor signaling,
neurotransmitter secretion, inflammation and growth
factor receptors, we still see a mix of same and opposing
directions of expression of these genes between AY and
HC (Additional file 1: Figure S2). Some of the DEGs in-
volved in social withdrawal, immobility, long-term memory,
and startle, anxiety and fear responses were down-regulated
in AY (Additional file 1: Figure S3). Many of these down-
regulated genes were also found to be associated with
neurotrophic factors signaling, fear extinction, and func-
tions related to emotional regulation.
As suppressed or induced expression of associated
genes does not necessarily correspond to the activation
Figure 2 Modular networks of DEGs associated with circadian clock, behavioral response and synaptic transmission; each module
(nodes of the same color) forms a functional module.
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sponses, we calculated an activation z-score for each sig-
nificantly enriched behavior and biological process based
on the expression values of associated DEGs in each
brain region at each time point. This approach is im-
portant to further identify which behavioral responses
and biological processes may have been activated or
inhibited. For example, Figure 5 shows the activation
pattern of anxiety-like behavior in AY, HC and MPFC at
both early (T5R1, T10R1) and late (T5R10, T10R42) rest
periods. Here, it is more obvious how the expression dir-
ection of each DEG contributes to the predicted activa-
tion (red central node) or inhibition (blue central node)
of the anxiety-like behavior (Figure 5). The pattern be-
came clearer not only within a single network but also
in comparison among different brain regions and time
points. At T10R1, genes associated with anxiety-like be-
havior are activated in AY but inhibited in the MPFC,
which is consistent with reported observations of exagger-
ated activation of AY and delayed regulation by MPFC
during early stage amygdala-dependent fear responses
[34,35]. On the other hand, at longer rest periods (T5R10,
T10R42), the opposite pattern of activation occurred be-
tween AY and MPFC (Figure 5), which may indicate
that the attenuation of the anxiety-like response in AY
was probably due to emotional regulation by MPFC.
Anxiety-like behavior also showed activation or attenuationat earlier and at later rest periods, respectively, in AY
(Additional file 1: Figure S4). Activation z-scores for
fear conditioning and startle response in AY, HC and
MPFC also showed different activation or attenuation
patterns across time points and regions (Additional file 1:
Figures S5 and S6).
The activation z-score for each enriched process at every
time point showed increased activation of many of the
anxiety-related behavioral responses at one-day post Agg-E
(particularly in AY at T10R1) and a slight attenuation (but
still an activated pattern) at longer rest periods (Figure 6).
A similar approach for visualizing the signaling pathways
related to synaptic plasticity and neurogenesis showed
largely inhibited patterns (Figure 7).
Whereas we observed increased predicted activation of
pathways implicated in behavioral responses, there was,
in contrast, a decreased predicted activation in a broad
spectrum of pathways pertaining to synaptic plasticity
and neurogenesis (Additional file 1: Figure S7). There
were, however, a few important exceptions such as loss
of neurons, long-term synaptic depression (activated in
AY, HC & MPFC) at T5R1, and activation of many of
these signaling functions in AY at T10R1, and in HC
(and to some extent in MPFC) at T10R42 (Additional
file 1: Figure S7). This may be related to many of the ele-
vated neuronal activities of AY since it is the center of
fear and anxiety responses at one-day post Agg-E. On
Figure 3 Networks of DEGs involved in associative learning, fear memory extinction, and aggressive and territorial behaviors.
Nodes are colored using AY_T10R1 and HC_T10R1.
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neuronal signaling may be more active in the HC due to
long-term memory consolidation and related processes
and in the MPFC since it is involved in regulating emo-
tional responses.
Our assays and analyses showed that many genes re-
lated to PTSD-associated behaviors such as startle re-
sponse (Figure 6 and Additional file 1: Figure S7), rearing,
cognitive impairment, hyperactivity, anxiety, addiction,
avoidance and fear conditioning (Additional file 1:
Figure S7), had differential activation across tissues and
time points, the larger activation generally being at one-
day post-10 days of Agg-E (T10R1) sessions (Figure 6
and Additional file 1: Figure S7). Synaptic transmissions,
including secretion and concentration of neurotransmit-
ters, long-term potentiation, and synaptogenesis (Figure 7)
were largely inhibited at one-day post-10 days of Agg-E
(T10R1) and 10-days post-5 days of Agg-E (T5R10).
We observed that neurotransmission and synaptic plasti-
city tend to be inhibited across tissues and time pointscompared to behavioral responses and neurological disor-
ders, indicating impaired cognition and mood disorders
(Figure 6), which are important facets of anxiety disorders.
Networks of transcripts important in behavioral stress
responses, synaptic transmission and circadian rhythm
Modular networks of DEGs from different brain regions
have been significantly associated with associative learn-
ing, long-term memory, and regulation of serotonergic
and dopaminergic synaptic transmissions, cognition, neuro-
genesis, limbic system development, startle and fear re-
sponses, and circadian rhythm (Figure 2). These pathways
and biological processes are important molecular signaling
implicated in traumatic responses leading to anxiety-related
disorders.
Comparative transcriptome changes among brain regions
important in stress response circuitry
Transcriptome alterations in AY and HC were compared
for overlapping and differential biological processes and
Figure 4 Networks of DEGs involved in circadian rhythm and corticotropin releasing factor signaling. Nodes are colored using AY_T10R1
and HC_T10R1.
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ported to be involved in startle and fear responses, social
withdrawal, long-term memory, circadian rhythm, cor-
ticotropin releasing hormone receptor signaling, associa-
tive learning, aggressive and territorial behavior, and fear
memory extinction (Figures 3 and 4 and Additional file 1:
Figure S3). Red nodes show activation and blue nodes show
inhibition of these particular behaviors. Many showed op-
posite regulation in AY compared to their expression in
HC for the one-day post 10-days Agg-E session (T10R1)
(Figures 3 and 4 and Additional file 1: Figure S3). These
data suggest that there are opposing forces acting in
AY compared to those molecular events in HC under
severe stress or traumatic conditions possibly with incipi-
ent stress disorders.
Common and specific transcripts for 5- and 10-day
aggressor exposure sessions with different post Agg-E
tissue collection rest (delay) days
Among DEGs from brain regions at different time
points, 2,470 were associated with behavioral stress re-
sponses, synaptic plasticity and transmissions, circadian
rhythm, obesity and diabetes, and inflammatory re-
sponse. Of the 2,470 DEGs, 62 were specific to T10R1,
106 to T5R1, 103 to T5R10, 401 to T10R42, and 306were common among all time points. The 306 common
DEGs were significantly (Bonferroni, q < 0.05) associated
with axon guidance, neurotransmitter secretion, opioid
signaling, G-protein mediated events, downstream TCR-
signaling, regulation of synaptic plasticity, associative
learning, synapse assembly, CNS neuronal axonogenesis,
long-term potentiation, long-term depression, activation
of NMDA receptor and synaptic vesicles exocytosis
(Additional file 1: Figure S8). The T5R1-specific 106
DEGs were associated with positive regulation of chronic
inflammatory response, associative learning, dendritic
spine development, negative regulation of axon exten-
sion, and the regulation of production of interleukins 10
and 12. The103 DEGs specific to T5R10 were associated
with regulation of the perception of pain, response to
carbohydrate stimuli, and organic acid transport. The
T10R1-specific 62 DEGs were associated with positive
regulation of circadian sleep/wake cycle, regulation of
nerve growth factor receptor signaling pathways, nega-
tive regulation of cardiac muscle cell apoptosis, and
cytotoxic activity; and the DEGs specific to T10R42
were associated with inflammatory and adaptive immune
responses. It appeared that some of the biological pro-
cesses and pathways relevant to traumatic stress re-
sponses started occurring early (during T5R1). On the
Figure 5 Activation pattern of anxiety-like behavior in amygdala (AY), hippocampus (HC) and medial prefrontal cortex (MPFC) and
expression directions of associated genes.
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ger rest periods were associated with pain perception
(T5R10) and the immune response (T10R42).
Activation patterns of behavioral response and comorbid
conditions
Traumatic stress disorder-related behaviors such as fear
conditioning, anxiety-like behavior and startle responses
showed differential activation patterns across the brain
regions of AY, HC and MPFC at different time points
(Figure 6 and Additional file 1: Figure S7). Fear conditioning-
related genes were activated in the HC and MPFC (except
T5R10) throughout the experimental time courses, but in
the AY, this was activated at the early defeat period and
attenuated at longer defeat periods (Figure 6). Early induc-
tion of transcripts implicated in fear conditioning sug-
gested activation of this behavioral response early,
consistent with the observation that AY responds first to
traumatic stress. In the case of anxiety-like behaviors,
transcripts associated with this process were induced in
MPFC after the longer rest periods (T5R10 and T10R42),
which is an indication of a delay in MPFC responses toanxiety-like disorders compared to AY (Figure 5). On the
other hand, transcripts associated with anxiety show
that AY responds at early periods and this response was
greatly diminished with longer rest period after the
traumatic event (Additional file 1: Figure S4). Although
signs of inhibition of anxiety-like behavior at longer rest
periods in AY indicated a sense of recovery, its activa-
tion in HC and MPFC in particular (Figure 5) suggested
that it may precipitate in the forms of mood disorder
and impaired cognition.
Comorbid conditions of anxiety disorders such as in-
flammation, obesity, diabetes and cardiac infarction were
also among significantly enriched processes and path-
ways (Table 2). These observations suggest the pervasive
and debilitating effect of resident-intruder social stress
on the health of the Agg-E mice.
Transcript – brain-region interactome across time points
We constructed transcript – brain-region interactome
using transcripts that passed p-value less than 0.01 and
more than 2 fold across brain regions and time points
(Figure 8). Persistent with what we observed with whole
Figure 6 Behavioral response and neurological disorders associated with DEGs of brain regions at four different time points.
Figure 7 Neuronal signaling, synaptic plasticity and neurogenesis associated with DEGs of brain regions at four different time points.
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Table 2 Differentially regulated genes (DEGs) significantly associated with different behavioral responses, neuronal
signaling processes and comorbid conditions
q-Value Associated DEGs
Behavioral response
anxiety 4.37E-17 APP,BDNF,CCK,CNR1,CREB1,CRH,CRHR1,DRD2, FKBP5,FOS,MAPK1,NPY,NTRK2
anxiety-like behavior 3.10E-10 APP,BDNF,CCK,CRH,CRHR1,MAPK1
cognition 9.54E-24 AKT1,APP,BDNF,CNR1,CREB1,CRH,CRHR1, DRD2,EP300,ERK1/2,FOS,GNAI1,
HDAC3,KL,MAPK1,MAPK3,NGF,NPY,NR3C1,NTRK1,NTRK2,PI3K (complex),THRB
cognitive impairment 2.94E-10 APP,BDNF,CNR1,CRH,DRD2,LEP,NGF,NPY
conditioning 4.06E-12 APP,BDNF,CNR1,CREB1,CRHR1,DRD2,ERK1/2, GNAI1,HDAC2,MAPK1,NPY
depressive disorder 7.59E-10 APP,BDNF,CCKBR,CREB1,CRH,DRD2,FKBP5, NR3C1,NTRK1,THRB
emotional behavior 3.83E-15 APP,BDNF,CCK,CNR1,CREB1,CRH,CRHR1,DRD2, MAPK1,MAPK3,NGF,NPY,NTRK2
learning 1.25E-21 AKT1,APP,BDNF,CNR1,CREB1,CRH,CRHR1,DRD2, EP300,ERK1/2,FOS,GNAI1,HDAC3,
HOMER1,MAPK1,MAPK3,NGF,NPY,NR3C1,NTRK1,NTRK2, PI3K (complex),THRB
locomotion 6.56E-11 APP,BDNF,CCKBR,CNR1,CRH,CRHR1,DRD2,LEP, NGF,NR3C1,STAT3
long-term memory 1.37E-15 APP,BDNF,CREB1,CRH,DRD2,ERK1/2,GNAI1, HDAC3,MAPK1,NTRK2
memory 5.63E-20 AKT1,APP,BDNF,CNR1,CREB1,CRH,CRHR1,DRD2, EP300,ERK1/2,GNAI1,HDAC3,
HOMER1,MAPK1,NGF,NPY,NR3C1,NTRK1,NTRK2, PI3K (complex)
Mood Disorders 2.80E-10 AKT1,APP,BDNF,CCKBR,CREB1,CRH,DRD2, FKBP5,NR3C1,NTRK1,PLCG1,THRB
neurological signs 2.63E-11 AKT1,APP,BDNF,CCKBR,CNR1,CREB1, CTNNB1, DRD2,FOS,LEP,NGF,NPY,NTRK2,PRL
neuromuscular disease 1.45E-10 AKT1,APP,BDNF,CCKBR,CNR1,CREB1, CTNNB1,DRD2,FOS,LEP,NGF,NPY,NR3C1,
NTRK2, PRL
object recognition memory 1.69E-09 APP,CNR1,EP300,HDAC3,NGF
post-traumatic stress disorder 5.32E-14 ADRA1A,ADRA1B,ADRA2A,ADRA2B,ADRA2C, ADRB1,CNR1,CNR2,DRD1,DRD2,
DRD3,DRD4,DRD5,HTR1A,NR3C1,SLC6A4
recognition memory 2.36E-13 APP,CNR1,EP300,GNAI1,HDAC3,MAPK1,NGF, NR3C1
spatial learning 3.72E-10 APP,BDNF,CREB1,CRHR1,DRD2,FOS,NGF,NTRK2
spatial memory 2.95E-11 AKT1,APP,BDNF,CNR1,CREB1,DRD2,NGF,NPY, NR3C1,PI3K (complex)
Neuronal signaling and neurogenesis
activation of neurons 1.22E-10 APP,BDNF,CCK,CNR1,CRH,FOS,LEP,NGF,PI3K (complex)
atrophy of neurons 4.63E-10 APP,BDNF,NGF,NTRK1,NTRK2
axonogenesis 1.84E-11 AKT1,APP,BDNF,CCK,CREB1,DRD2,FOS,NGF,NTRK1,NTRK2
cell death of hippocampal neurons 1.51E-09 AKT1,APP,BDNF,CRHR1,DRD2,LEP,NGF, NTRK2
concentration of corticosterone 1.28E-13 APP,CNR1,CRH,CRHR1,DRD2,LEP,NPY,NR3C1, NTRK2,STAT3
concentration of cyclic AMP 3.58E-09 ADCY,APP,BDNF,CCK,CNR1,CRH,DRD2,LEP,NGF, PRL
degeneration of neurons 2.07E-09 AKT1,APP,BDNF,CNR1,CREB1,EP300,NGF,NTRK2, STAT3
dendritic growth/branching 6.77E-11 AKT1,APP,BDNF,CNR1,CRH,CRHR1,DRD2,NGF, NTRK2
depolarization of cells 1.34E-10 APP,BDNF,CCK,CRH,FOS,LEP,NPY
disorder of basal ganglia 2.28E-10 AKT1,APP,BDNF,CCKBR,CNR1,CREB1, CTNNB1,DRD2,FOS,LEP,NGF,NPY,NTRK2,PRL
excitation of neurons 4.23E-12 APP,BDNF,CCK,CRH,FOS,NGF,NPY,NTRK2
length of dendrites 1.78E-12 APP,BDNF,CRH,CRHR1,NGF,NTRK2
long-term potentiation 4.96E-15 APP,BDNF,CNR1,CREB1,CRHR1,DRD2,ERK1/2, GNAI1,HDAC2,MAPK1,MAPK3,NGF,
NPY,NTRK2, PI3K (complex)
long-term potentiation of synapse 1.44E-12 APP,BDNF,CNR1,CREB1,DRD2,GNAI1,HDAC2, MAPK3,NTRK2
loss of dorsal root ganglion cells 4.01E-10 BDNF,NGF,NTRK1,NTRK2
mobilization of Ca2+ 3.95E-10 BDNF,CCK,DRD2,GNAI1,GNB2, inositol triphosphate,NGF,NPY,PI3K (complex),
PLCG1,RXFP3,SRC
neuronal cell death 1.68E-15 AKT1,APP,BDNF,CNR1,CREB1,CRHR1,CTNNB1,DRD2,EP300,ERK1/2,FOS,HDAC3,
LEP,MAPK1,NGF,NR3C1,NTRK1,NTRK2,PI3K (complex),SRC,STAT3
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Table 2 Differentially regulated genes (DEGs) significantly associated with different behavioral responses, neuronal
signaling processes and comorbid conditions (Continued)
neuroprotection 4.24E-09 AKT1,APP,BDNF,CNR1,CRH,CRHR1,LEP,NGF,PI3K (complex)
neurotransmission 3.60E-17 APP,BDNF,CCK,CCKBR,CNR1,CRH,CRHR1, CTNNB1,DRD2,ERK1/2,GNAI1,HDAC2,
LEP,NGF, NPY,NR3C1,SRC
proliferation of neuronal cells 2.13E-09 BDNF,CNR1,CTNNB1,DRD2,ERK1/2,LEP,NGF, NTRK2,PI3K (complex),STAT3
quantity of ACTH in blood 4.32E-09 CNR1,DRD2,NR3C1,NTRK2
quantity of neurons 4.71E-12 APP,BDNF,CREB1,DRD2,ERK1/2,LEP,NGF,NPY, NTRK1,NTRK2,PRL,THRB
quantity of pituitary cells 2.10E-11 CRH,CTNNB1,DRD2,LEP,PRL,THRB
release of acetylcholine 3.84E-09 APP,BDNF,CNR1,CRH,DRD2,NGF
release of Ca2+ 3.82E-09 AKT1,APP,BDNF,CCK,DRD2, inositol triphosphate,LEP,NGF,PI3K (complex),
PLCG1,SRC
release of catecholamine 3.32E-14 APP,BDNF,CNR1,CRHR1,DRD2,LEP,NGF,NPY, NTRK1,NTRK2,PRL,SRC
release of dopamine 1.84E-11 APP,BDNF,CNR1,CRHR1,DRD2,LEP,NGF,NTRK2, PRL
release of L-glutamic acid 1.12E-11 ADCY,APP,BDNF,CCK,CNR1,CRH,DRD2,LEP,NGF, NPY
secretion of catecholamine 2.06E-12 AKT1,APP,CNR1,CRH,CRHR1,DRD2,NPY,NTRK1
secretion of corticosterone 4.27E-12 BDNF,CRH,CRHR1,DRD2,LEP,NPY
secretion of neurotransmitter 3.44E-10 CCK,CNR1,CRH,DRD2,NGF,NPY,NTRK1,NTRK2
stimulation of neurons 4.28E-13 APP,BDNF,CCK,CRH,FOS,LEP,NGF,NPY,NTRK2
synaptogenesis 2.22E-10 APP,BDNF,CREB1,CTNNB1,HDAC2,NGF,NTRK1, NTRK2
synthesis of neurotransmitter 7.69E-10 AKT1,APP,BDNF,CRH,NGF,NTRK1
synthesis of steroid 3.71E-09 APP,BDNF,CREB1,CRH,CRHR1,LEP,MAPK1,NR3C1,PI3K (complex),PRL,PROX1
Comorbid conditions








myocardial infarction 6.49E-12 AKT1,AKT1,APP,CNR1,CREB1,CTNNB1,DRD2,EP300, ERK1/2,FOS,HDAC2,HDAC3,
KL,LEP,MAPK1, MAPK3,NPY,NR3C1,STAT3,THRB,GPX3, SRC
hypertrophy of cardiomyocytes 6.16E-06 AKT1,EP300,HDAC2,LEP,MAPK1,PI3K (complex), STAT3
coronary artery disease 3.08E-04 APOE, CNR1,FOS,HDAC2,KL,NR3C1, LEP
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reversed for the early (5d1d) and for the late (10d42d)
time points for transcripts filtered with stricter cut offs.This corroborates our suggested activation and inhib-
ition of behavioral responses across time points among
AY, HC and MPFC. Transcripts at early time point
Figure 8 Transcripts – brain-regions interactome for transcripts that passed p-value less than 0.01 and fold change greater than 2.0 in
Agg-E groups compared to control groups (across time points).
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suppressed in HC (Figure 8, Additional file 1: Figure S9).
On the other hand, transcripts at later time point
(10d42h) showed reversed expression pattern between AY
and HC (Figure 8, Additional file 1: Figure S12), which is
again consistent with our expression based prediction ana-
lyses. At the transcript level, there were not many shared
DEGs among combinations of brain-regions and time
points. But there were more overlaps at the pathway and
process levels (Additional file 1: Figures S9-S18).
A large portions of these sets of transcripts were asso-
ciated with splice variant processing and activities of
zinc finger transcription factors (Figure 9 and Additional
file 3: Table S2). Many of these transcripts were also
shared also with those transcripts suggested to be in-
volved in traumatic disorders and comorbid conditions
(Figure 9 and Additional file 3: Table S2).
Validation of gene expression profiles
Transcripts implicated in anxiety and fear responses in
PTSD patients and animal models were assayed in each
brain region (AY, HC, MPFC, SE, ST and VS) at the
T10R1 time point using the QuantiGene Plex 2.0 Reagent
System (Multiplex) to corroborate our microarray results.Many of the samples assayed by the QuantiGene Multi-
plex showed comparative direction of expression with
that of microarray data (Additional file 1: Figures S19.a
and S20). Transcripts critical in nerve growth factor and
synaptic plasticity such as FK506 binding protein 5
(Fkbp5), brain-derived neurotrophic factor (Bdnf ), thy-
roid hormone receptor beta (Thrb) and prostaglandin-
endoperoxide synthase 2 (Ptgs2) were largely suppressed
in both microarray and QuantiGene assays. Transcripts
of the neuronal signaling molecules (substrate specific
channels) such s Slc1a2 was up-regulated and Il1rap was
down-regulated in all regions except in AY, while Rxfp3
and Prox1 were up-regulated in AY, HC and MPFC re-
gions (Additional file 1: Figures S19.a and S20).
Correlation analysis for each transcript between the
bead and array data showed directional correlation for
the transcripts: Fkbp5, Thrb, Il1rap, Bdnf, Drd2, Slc1a2,
Coch, Gng4, Rxfp3 and Slc1a2; while Gpx3, Npy, Prox1
and Ptgs2 showed lower directional correlation between
the two platforms (Additional file 1: Figures S19 and S20).
Rxfp3, Gng4 and Slc1a2 showed overall opposite correl-
ation compared to the rest of the transcripts as shown
by the correlation matrix of all the assayed transcripts
(Additional file 1: Figure S19.b). These transcripts were
Figure 9 Pathways and biological processes significantly associated with transcripts (with p-value < 0.01, and fold change > 2.0) shown
in Figure 8. Sizes of the hollow-pie sectors were proportional to the number of transcripts associated with that particular pathway or process.
Gene expression related processes such as activities of zinc finger protein transcription factors, and splice variant processing were associated with
larger numbers of transcripts (and many of these were also shared with pathways related to trauma/fear related behavioral responses).
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where as the other transcripts showed similar correl-
ation and were largely down-regulated in the two plat-
forms (blue ellipses) (Additional file 1: Figure S19.b).
This also corroborated the notion that neurogenesis re-
lated brain factors were suppressed whereas some of
transcripts implicated substrate specific channels and
neuronal signaling were induced at the molecular level.
Discussion
Cellular and molecular changes in the activity and func-
tional connectivities among the amygdala (AY), hippo-
campus (HC), medial prefrontal cortex (MPFC) play
primary roles in fear learning and memory, and thus,may contribute to the behavioral manifestations of anx-
iety disorders (Additional file 1: Figure S1).
Identification of the molecular basis of learning and
memory mechanisms across stress-induced anxiety disor-
ders is critical for devising means of mitigating the severity
of traumatic disorders. This is because both memory re-
trieval (involved in symptom expression, reconsolidation,
and maintenance of these disorders), and memory extinc-
tion (believed to be the mechanism of behavioral exposure
therapy of anxiety disorders) are dependent on transcrip-
tional changes of the underlying molecules governing syn-
aptic plasticity and inter-neuronal signaling.
Transcripts significantly associated with synaptic transmis-
sion and plasticity, long-term depression and potentiation,
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mitters such as glutamate, acetylcholine, dopamine and
serotonin were differentially regulated across time points
and brain regions due to the effects of social stress trauma
on Agg-E mice. These molecular changes are corroborated
by changes in other groups of transcripts associated with
behavioral expression of anxiety disorders such as startle
response, anxiety, hyperactivity, fear conditioning, emo-
tional behavior, cognitive impairment, and addiction and
alcohol abuse-associated behaviors. Molecular indicators
of addiction and alcohol abuse showed increased activa-
tion z-scores (Additional file 1: Figure S7A), which cor-
relates with the observations of others that traumatic
events sufficient to produce long-lasting enhancement
of fear learning also increase voluntary ethanol con-
sumption [36].
DEGs involved in synaptic transmission in relation to
long-term synaptic potentiation, long-term synaptic de-
pression, and synaptic plasticity are the basis for learning
and memory consolidation. These pathways and func-
tional enrichment findings may indicate the acquisition,
consolidation and maintenance of traumatic memories
to form anxiety disorders via fear learning and fear mem-
ory circuitry, as well as deficiencies in extinction and
re-extinction mechanisms along the different time course
trajectories in different brain regions. For example, the AY
had higher activation z-scores of anxiety-related behaviors
at earlier time points compared to the MPFC, which cor-
responded with the earlier response in the amygdala. This
supports the belief that neural circuits underlying PTSD
are characterized by exaggerated AY activation and de-
creased MPFC activation, leading to the elevated anxiety
state and concomitant inadequate emotional regulation
[37]. Re-experiencing the traumatic event in the form of
recurrent distressing images and recollections, including
the intrusive traumatic memory, is unique to PTSD
among anxiety disorders [17,38], and is probably due to
diversion of focus from the current stimuli (caused by im-
paired cognition due to slow acting MPFC) to the intru-
sive traumatic event (interference effect of the faster paced
AY activities).
In addition, DEGs reported to be involved in the fear-
potentiated startle response, fear extinction resistance,
associative fear learning, and cue conditioning were indi-
cative of the formation of traumatic memories and a vul-
nerability to developing fear-related anxiety disorders. For
example, the transcripts FKBP5 and BDNF were sup-
pressed across the six brain regions at T10R1 (Additional
file 1: Figures S19.a and S20). FKBP5 is involved in the
behavioral and neuroendocrine effects of chronic social
defeat stress. Suppression of FKBP5 expression in HC
leads to persistent traumatic disorder and confers fear ex-
tinction resistance [22,23]. BDNF is a crucial regulator of
neuroplasticity, which underlies learning and memoryprocesses in different brain areas. Chronic suppression of
BDNF expression in the HC, AY and the prefrontal cortex
leads to a deficit in the acquisition of extinction memory,
and increased BDNF expression supported amelioration of
hyperarousal in a mouse model of PTSD [39]. BDNF facil-
itates extinction learning, and decreased mRNA expres-
sion of BDNF within the MPFC leads to resistance to fear
extinction. Activation of BDNF signaling by the TrkB
agonist 7, 8-dihydroxyflavone blocks the return of fear
after extinction training [40,41].
The exact social stress process that we used here was
also shown to result in decreased BDNF in the HC, which
led to suboptimal binding of BDNF to tyrosine receptor
kinase B (TrkB), resulting in curtailing downstream intra-
cellular signaling pathways, including mitogen-activated
protein kinase/extracellular signal-regulated protein kinase
(MAPK/ERK), phospholipase Cg (PLCg), and phosphoino-
sitide 3-kinase (PI3K) pathways. These pathways are im-
portant for neurogenesis and cognition [42,43]. Another
important DEG along this pathway is the nerve growth
factor, Ngf, that also shown to bind to tyrosine receptor
kinase A (TrkA). In response to Ngf, the TrkA forms a
complex with Shc, coupling TrkA to p21ras and Shc with
Grb2, which is mediated by autophosphorylation of TrkA
[44]. However, suppression of Ngf at earlier time points
(T5R1 and T10R1) suggestive of curtailed kinase activities
and complex formations, potentially leading to impaired
synaptogenesis.
Potential contribution to the etiology of PTSD may be
due to sensitization of glucocorticoid receptor (GR) sig-
naling and dysregulation of GR modulators [45] such as
FKBP5 and Crf1 receptors. Furthermore, Akt, Nfkb and
MAP kinases, which are G protein-coupled receptor
(GPCR) pathway molecules, can promote or prevent
sustained high anxiety- and depressive-like behaviors fol-
lowing severe stress. Agonist-induced activation of the
corticotropin releasing factor (Crf1 receptor) is crucial
for survival in the context of serious danger or trauma,
but persistent Crf1 receptor hyper-signaling when a
threatening or traumatic situation is no longer present is
maladaptive. Also, suppressed expression of Grk3, which
phosphorylates the Crf1 receptor protein indicates there
was suboptimal binding of Crhr1 with beta-arrestin2,
leading to inhibited termination of Grk3-coupled Crf1
receptor signaling by homologous desensitization. This
deficiency in Grk3-beta-arrestin2 complex formation is
suggested to contribute to PTSD and co-morbid post-
traumatic depression [46].
FKBP5 is also shown to mitigate HPA axis dysfunction
[47]. Molecular changes involved in modulation of the
HPA axis are associated with cue conditioning, calcium
signaling, memory processes, and regulation of the stress
responses. Transcripts of genes involved in HPA axis,
such as those related to corticotrophin releasing factor
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ceptor signaling and oxytocin receptor (such as Nr3c1,
Nr3c2, Crhr1, Crhr2, Oxtr) were also differentially regu-
lated. Oxytocin (mammalian neuropeptide) modulates
activation of fear extinction-based neural circuits and
fear responses [48].
Release of GC, CRF and modulators are shown to
affect emotional learning and memory in relation to eti-
ologies of anxiety disorders. The pathogenesis of PTSD
is attributed to over-consolidated traumatic memories
that are mediated by endogenous stress hormones re-
leased during and after trauma. Downstream secondary
messenger signaling pathways with a putative role in
long-term potentiation (LTP), such as inositol 1,4,5-tris-
phosphate (IP3) and diacylglycerol (DAG) with the up-
stream enzyme inositol monophosphatase (Imp), favor
fear learning and traumatic memory consolidation in
traumatized and susceptible individuals via fear potenti-
ated LTP, and the eventual development of PTSD [49].
Glucocorticoid increase after longer rest periods in Agg-
E mice is probably an indicator of attenuated condi-
tioned fear and is in agreement with the observation that
stress-induced circulating cortisol was shown to reduce
memory retrieval of conditioned fear in men [50].
Transcript levels of genes reported to be associated
with cognition and object recognition (in particular, sup-
pressed expression of BDNF, Gnai1, App, Ep300, Cnr1,
Cnr2 and Ngf transcripts) at one-day post-10 days of
Agg-E session (T10R1) indicated there was impaired
cognition, and therefore, inhibition of novel object rec-
ognition. The memory modulating cannabinoid recep-
tors (Cnr1 & Cnr2) and elevated levels of endocannabinoids
(endogenous cannabinoids) in the basolateral AY and have a
critical function in the extinction of aversive memories.
Cnr1-deficient mice showed strongly impaired short-term
and long-term extinction in auditory fear-conditioning
tests, with unaffected memory acquisition and consolida-
tion. Treatment of wild-type mice with the Cnr1 (CB1
receptor) antagonist SR141716A mimicked the phenotype
of CB1-deficient mice, suggesting that CB1 is required
at the moment of memory extinction. In the basolateral
AY, endocannabinoids and CB1 were crucially involved
in long-term depression of GABA (gamma-aminobutyric
acid)-mediated inhibitory currents [51,52].
Alternatively, transcripts of the histone deacetylases
(Hdac2 & Hdac3) showed increased expression, also indi-
cating impaired object recognition. Impaired object recog-
nition memory may underlie certain avoidant symptoms
or negative cognitions in PTSD and be related to impaired
behavioral flexibility [53]. Impaired novel object recogni-
tion parallels neurocognitive deficit (impaired memory
and attention) in PTSD patients who show lower perform-
ance on memory tests specific to learning and executive
functions [54].Other important DEGs include cFos and its (pro-
moter) histone deacetylase enzyme, Hdac2, GluN2B
(Dusp1), and klotho (Kl). Hdac2 and cFos play a critical
role in fear memory recall for reconsolidation and up-
dating acquired memories in neuronal plasticity [38,39].
A similar social defeat model showed that presentation
of an aggressor cue induced robust increases in cFos in
AY, MPFC and CA1 of HC both 1 and 7 days after Agg-
E. The increase at 7 days is greater than that at one day,
whereas avoidance behavior was great at one day post-
Agg-E and had somewhat abated by 7 days post-Agg-E.
This suggests that increased neuronal processing was re-
lated to the decrease in avoidance [55]. In the condi-
tioned fear paradigm of mice, fear memory extinction is
shown to be more effective in a one-day-old fear mem-
ory compared to a 30-day-old fear memory. Older fear
memories are less labile due to hypoacetylated c-Fos
promoter by Hdac2 in HC [56]. Among others, this may
be one reason why we observed more DEGs after 42 days
of rest (T10R42) compared to one-day post 10-day Agg-
E sessions (T10R1), with related DEGs activated upon
remote memory recall [39,40]. Elevated K1 in mice has
been shown to enhance long-term potentiation (synaptic
plasticity), and enrich synaptic GluN2B (an NMDA re-
ceptor subunit) with key functions in learning and mem-
ory. Blockade of GluN2B abolished klotho-mediated
effects. Suppressed expression of K1 may indicate cogni-
tive deficits in our model animals [57].
Overall, transcripts of DEGs in Agg-E groups of mice
compared to controls in the different brain regions were
reported to be associated with glucocorticoid negative
feedback signaling, arousal to trauma cues (jumping), im-
paired aggressive behavior (avoidance of aggressor-cued
partition), social withdrawal, impaired territorial behavior,
long-term fear memory, grooming, decreased movement,
anxiety, long-term synaptic depression and potentiation
(long-term synaptic plasticity), inhibited dopaminergic
signaling, HC atrophy, dendritic branching in AY, condi-
tioned fear association, fear memory consolidation, retrieval
and impaired contextualization, sensorimotor gating deficit,
deficit of executive function, impaired object recognition,
and circadian rhythm disruption (Table 2).
Significant association of DEGs with comorbid condi-
tions, such as chronic inflammation, myocardial infarc-
tion, suppressed protective immunity and obesity/
diabetes indicate the pervasive nature of Agg-E, leading
to many systemic pathological consequences. Previous
studies using this same mouse model simulating PTSD
showed acute myocardial injury associated with the trau-
matic experience as a consequence of underlying bio-
logical injury processes, including inflammation [58].
Metabolomic, histopathology and liver transcriptomic
analyses showed increased inflammatory response at
one-day post-stress, persistent myocarditis and cardiac
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of heart disease and obesity [59]. Similar co-morbidities
of PTSD observed in veterans and active duty personnel
include inflammation, obesity, diabetes, and heart dis-
ease [3], as well as sleep disorders [60,61] and higher
rates of pain, possibly due to chronic inflammation [62].
Altered trauma induced behavioral responses and as-
sociated comorbid pathways (discussed before and add-
itional pathways) were also significantly associated with
the more significant transcripts (with p < 0.01, and fold
change > 2.0) (Figure 9 and Additional file 1: Figures S9-
S18). Additional pathways related to splice variant pro-
cessing, mitochondrial dysfunction, metabolic disorder,
substrate specific channel activities, activities of zinc fin-
ger related transcription factors and cytoskeletal protein
binding were significantly enriched (Figure 9). Associ-
ation of many of the top transcripts with splice variant
processing may hint to the basis of molecular mecha-
nisms leading to either stress resilience or susceptibility
among individuals. Transcripts associated with mito-
chondrial dysfunction along with those involved in
metabolic disorder may contribute towards exaggerated
fear in traumatized individuals [63].
Conclusions
Pathways and functions presumably important for the
etiology of PTSD-like disorders, including endocannabi-
noid signaling, HPA axis function, modulators and tar-
gets of cortisol, neuronal transmission, neurogenesis and
fear memory extinction with regard to emotional learn-
ing and memory, and a number of anxiety-related behav-
ioral responses were significantly associated with DEGs.
Activation z-scores of anxiety-related behavioral re-
sponses, fear acquisition and consolidation-related sig-
naling pathways and processes reveal the distinct, and
probably complementary roles of early time points ver-
sus later rest periods (of 5-day and 10-day Agg-E ses-
sions) in the traumatic fear-learning trajectories. The
molecular mediators of the earlier stress responses (first-
wave responders) seem to enhance fear maintenance (in
AY), whereas the second-wave of transcripts seem to ei-
ther consolidate fear memory (in HC) or attenuate fear
learning (in MPFC).
Future directions and suggested works
Advanced experimental tools, such as inducible muta-
tions in mice, virus-mediated gene transfer, and optoge-
netics provide the means to directly delineate the role of
specific proteins acting within specific cell types of
anxiety-processing brain structures in mediating PTSD-
like behavioral abnormalities in animal models.
There is evidence that females use different cognitive
strategies, exhibit increased stress sensitivity, and show
variations in reward-related behaviors throughout theestrus cycle that may render them more sensitive to the
deleterious effects of stress. Future studies may examine
the molecular and cellular underpinnings of anxiety-like
behaviors in females. For example, depression is twice
as likely to occur in women as in men [24], and this
may be true for other anxiety disorders as well, but ani-
mal studies including ours have mostly been conducted
in males.
Untreated traumatic fear memory in susceptible indi-
viduals precipitates in the form of anxiety disorders such
as PTSD. One effective treatment of anxiety disorder is
using exposure therapies, which are essentially traumatic
fear memory extinction and are effective during the la-
bile phase of fear memory consolidation. Since the win-
dow of fear memory consolidation is relatively short
compared to the enduring flashback vulnerability, re-
mote fear memories may not be persistently unlearned
by reconsolidation-updating paradigms. Hence, there is
a need to identify molecular mediators of stable fear
memory in order to devise a mechanism of extinction of
remote fear memory long after its consolidation window.
Methods
Exposure of subject mice to aggressor mice
Albino SJL male mice (The Jackson Laboratory, Bar
Harbor, ME) were single-housed for one month and
trained as aggressors by placing bulbectomized C57BL/6
male mice in SJL cages as intruders. [Note: the purpose
of bulbectomized C57BL/6J mice (which don’t fight
back) was only to train the SJL mice to be more ag-
gressive]. Naïve C57BL/6J male mice single-housed in a
separate room were used as experimental subjects (5
exposed and 5 control mice per time point were used).
Each subject mouse was kept in a protective mesh box
inside the cage of the aggressor SJL mouse for 6 hours/
day for 5 (T5) or 10 days (T10), with direct exposure to
the aggressor mouse for either 1 minute or 10 bites
(whichever occurs first) for 1–3 random times during
the 6-hour defeat session. Control (C-ctrl) mice were
also housed without feed and water for the same period
in a room separate from the aggressor mice.
Body weights and temperatures of the experimental
mice were measured (using implanted electronic ID
transponders) before and after the social defeat session
of each day. Details are given in separate publications
[29]. Territorial urine markings were measured by pla-
cing blotting papers (0.8 mm thick) under the cages of
Agg-E and C-ctrl mice. Areas were compared as de-
scribed in [29].
Assays for corticosterone levels
One hour after the partition test, mice were euthanized by
cervical dislocation and blood samples were immediately
drawn by cardiac puncture and collected in nuclease-free
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(0.105 M~ 3.2%). Whole blood samples were then centri-
fuged and plasma was separated and stored at −80°C until
the corticosterone assay was performed. Corticosterone
level was measured using an ELISA kit following the ma-
nufacturer’s instructions (Kamiya Biomedical Company,
Seattle, WA).
Brain dissection and collection of brain regions
Brain regions from subject and control C57BL/6 mice
were collected after one (R1) or 42 days (R42) of post
10-day (T10) aggressor exposure, and one (R1) or 10 days
(R10) after the 5-day (T5) aggressor exposure. Brains
were carefully removed from the skulls, and the left or
right hemi-brain from each traumatized or control
mouse was dissected into different anatomical and func-
tional regions: amygdala (AY), hippocampus (HC), med-
ial prefrontal cortex (MPFC), ventral striatum [including
nucleus accumbens] (VS), septal region (SE) and corpus
striatum (ST). Collected tissues were immediately frozen
in liquid nitrogen and stored at −80°C for total RNA
isolation.
RNA isolation
Total RNAs were isolated according to the Trizol® method
(Invitrogen, Inc., Grand Island, NY) from homogenized
brain regions. Isolated RNAs were stored at −80°C until
microarray assays were conducted.
Microarray hybridization
Microarray assays were performed using Agilent’s
genome-wide mouse expression array (GE 4x44K v2 two
color microarray) slides and kits (Agilent Technologies,
Inc., Santa Clara, CA) following the manufacturer’s proto-
col. Hybridized microarray slides were scanned using
Agilent Technologies Scanner G2505C US09493743.
Feature extraction and normalization
Images of scanned microarray slides were feature-
extracted and normalized using Agilent’s feature extrac-
tion software, version 10.7 or later, in the default setup
(Agilent Technologies, Inc.).
Microarray data analysis
Normalized data were filtered on flags to exclude probes,
which have missing values in more than one sample, and
these were tissue-wise quantile normalized using the
Limma Package of R program (www.r-project.org). Nor-
malized data were analyzed using Agilent’s Genespring
GX v12.0, the Limma package of R, and Qlucore Omics
Explorer 2.3 (Qlucore AB, Lund, Sweden). Each brain re-
gion at each time point (T5R1, T5R10, T10R1, and
T10R42) was compared for aggressor exposure effects:
Aggressor-Exposed (Agg-E) vs. Control (C-ctrl). DEGsin each tissue and time point were identified using a
Moderated T-test at p < 0.05 of the Limma Package of R.
Time effects were also compared using TimeClust
[64] across different combinations of aggressor expos-
ure sessions and rest periods (T5R1, T5R10, T10R1, and
T10R42).Behavioral association of DEGs with respect to functional
and pathway enrichments
To assess behavioral association of DEGs, we followed
two complementary approaches:
i. We started with DEGs across different brain regions
and identified significantly enriched signaling
pathways and biological processes.
ii. We used frequency calculation to determine
psychopatholy-related pathways and biological
processes cited in the scientific literature in relation
to social stress, trauma, PTSD, anxiety, and depression.
We then identified (from databases and literature)
transcripts and proteins directly associated with
the most frequently cited terms. Literature- and
database-mined genes and proteins were intersected
with DEGs from our study (brain regions), and
those in common were used to determine probable
downstream biological processes, as well as networks
and pathways and their significant associations.Gene ontology and pathway enrichments, regulatory
networks analysis, common pathways analysis, and
visualization
The Hypergeometric Test (false discovery rate (FDR),
q < 0.05) of Bingo 2.44 and ClueGO (Cytoscape 3.0.1 plug-
ins; http://www.cytoscape.org/), Fisher’s Exact Test of
Ingenuity® (Ingenuity, Inc., Redwood, CA), and Gene Set
Enrichment Analysis (http://www.broadinstitute.org/gsea/
index.jsp) were used for gene ontology and pathway en-
richments. The Cytoscape and Ingenuity Pathway analyt-
ical software systems were also used for network analyses
and visualizations. Common pathways were intersected
and visualized using Cytoscape and graphically displayed
using the R programming (www.cran-r.org) graphic system.
Activation z-scores of behavioral responses and synaptic
plasticity were used to identify induced and suppressed
behaviors and synaptic activities across brain regions
and time points.
Transcript – brain-region interactomes were constructed
and visualized using Gephi.0.8.2 beta (www.gephi.org).
Functions and pathways associated with the top transcripts
(p-value < 0.01, and fold change > 2.0) were enriched using
ClueGo, Bingo, IPA and David (using FDR correction of
q < 0.05). Bar charts of the corresponding processes and
pathways were constructed using the ggplot2 of R.
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Reagent system
Target–specific RNA molecules (Thrb, NM_009380; Ptgs2,
NM_011198; Prox1, NM_008937; Drd2, NM_010077;
Slc1a2, NM_011393; Rgs4, NM_009062; Hmga2, NM_
010441; Npy, NM_023456; Rxfp3, NM_178717; Gng4,
NM_010317; Bdnf, NM_007540; Coch, NM_007728; Il1rap,
NM_134103; Gpx3, NM_008161; Fkbp5, NM_010220)
from different brain regions were analyzed by the Quanti-
Gene Plex 2.0 Reagent system (Affymetrix, Fremont, CA).
Oligonucleotide probe sets (capture, label, and blocker
probes) for each gene were designed by the manufacturer.
Briefly, RNAs from different brain regions were captured
by fluorescent microspheres. After overnight hybridization
at 54 ± 1°C, hybridizations with branched DNA (bDNA)
pre-amplifier 2.0, bDNA amplifier 2.0, biotinylated label
probe and, finally substrate were sequentially carried out
according to the manufacturer’s instructions. Signals of cas-
cade amplification were detected by Bio-Plex 100 x MAP
technology and analyzed using Bio-Plex 6.0 software
(Bio-Rad Laboratories, Hercules, CA). Mean fluorescence
intensity (MFI) signals generated from each bead are pro-
portional to the amount of each mRNA captured on the
surface of each generated specific probe set [65].
The geometric means of four housekeeping genes (Ppib,
NM_011149; HPRT1, NM_013556; Ldha, NM_010699;
Rplp0, NM007475) were used for normalization of each
sample. Fold-changes were the relative ratios between nor-
malized values of treated groups and that of the control
group. Correlations between QuantiGene and microarray
data were calculated using GraphPad Prism® 5.04 (Graph-
Pad Software, Inc., La Jolla, CA).
The Pearson product moment (linear) correlation coef-
ficient and correlation significance for each transcript in
the microarray and Quantigene bead platforms were cal-
culated using base package of R. Correlation matrix was
calculated and plotted using corrplot package of R.
Data deposition
All datasets used in the study have been deposited in Gene
Expression Omnibus of NCBI [GEO accession #: GSE45035]
[http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45035].Additional files
Additional file 1: Supplemental Figures S1-S20.
Additional file 2: Table S1. Pathways and process associated with
differentially regulated transcripts across brain regions and time points
(Note: the p-value is the gene level; but the pathways and processes
were corrected using FDR at q < 0.05).
Additional file 3: Table S2. Pathways and process associated with
differentially regulated transcripts that passed p < 0.01 and fold
change > 2.0 (across brain regions and time points) (Note: the p-value
is the gene level; but enrichmenst of the associated pathways and
processes were corrected using FDR at q < 0.05).Abbreviations
PTSD: Post-traumatic stress disorder; Agg-E: Aggressor-exposed (social
stressed); C-ctrl: control; DEG: Differentially expressed gene;
HC: Hippocampus; AY: Amygdala; MPFC: medial prefrontal cortex; VS: Ventral
striatum, includes nucleus accumbens (NAc); SE: Septal region; ST: Corpus
striatum; T10 and T5: 10 days and 5 days of aggressor exposure sessions; R1,
R10 and R42: One, 10 and 42 (post-Aggressor exposure) days, respectively;
GPCR: G-protein-coupled receptors; FDR: False discovery rate.
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